SanBio Presents Interim Results of the First Intracerebral Stem Cell Transplant Study for Stroke in the United States

Dr. Damien Bates, Chief Medical Officer and Head of Research at SanBio will speak on a panel at AusBiotech 2016 on October 25 in Melbourne, Australia

Dr. Damien Bates, Chief Medical Officer and Head of Research at SanBio will speak at th 75th Annual Meeting of the Japan Neurosurgical Society on September 29 in Fukuoka, Japan

Publication “Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study”

Keita Mori, CEO of SanBio, will speak at New Economy Summit 2016 ”Session 1: Medical Innovation” in Tokyo on April 7

Keita Mori, CEO of SanBio will talk at 2015 World Alliance Forum in San Francisco ”Regenerative Medicine: Let’s Talk Business!” (Nov. 12-13)

Stanford-based research seeks to help stroke patients.

Northwestern Medicine Researchers Investigate Stem Cell Therapy for Stroke.

Stem Cell Applications Hasten into the Clinic.

Tesla Motors, SanBio Win First Salesforce.com Japan-US Emerging Leaders Awards.

« 前ページへ 次ページへ »